53,232 Shares in Cognex Corporation $CGNX Purchased by Blue Jean Financial LLC

Key Points

• Blue Jean Financial LLC acquired 53,232 Cognex shares worth approximately $3.23 million, making the stock 2% of its portfolio. Institutional investors collectively own 88.12% of Cognex.
• Cognex reported quarterly EPS of $0.45, exceeding estimates by $0.03, while revenue rose 16.9% year over year to $291.26 million. The company also issued a quarterly dividend of $0.085 per share, for an annualized yield of 0.6%.
• Analysts maintain a “Moderate Buy” consensus with an average price target of $75.57, compared with the stock’s reported price of $56.77. Price targets range from $65 to $91.

Blue Jean Financial LLC bought a new stake in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 53,232 shares of the scientific and technical instruments company's stock, valued at approximately $3,229,000. Cognex makes up about 2.0% of Blue Jean Financial LLC's holdings, making the stock its 17th largest position.

Other institutional investors have also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in shares of Cognex in the second quarter valued at about $1,158,123,000. Jupiter Topco LLC acquired a new stake in Cognex in the 2nd quarter worth about $161,425,000. Janus Henderson Group PLC boosted its holdings in Cognex by 81.0% in the 1st quarter. Janus Henderson Group PLC now owns 2,660,411 shares of the scientific and technical instruments company's stock worth $130,320,000 after buying an additional 1,190,434 shares during the last quarter. Bank of New York Mellon Corp acquired a new stake in Cognex in the 2nd quarter worth about $129,348,000. Finally, Arrowstreet Capital Limited Partnership increased its stake in Cognex by 115.6% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,033,091 shares of the scientific and technical instruments company's stock worth $99,601,000 after buying an additional 1,090,092 shares in the last quarter. Institutional investors and hedge funds own 88.12% of the company's stock.

Cognex Stock Up 2.9%

NASDAQ CGNX opened at $56.77 on Wednesday. The business's fifty day simple moving average is $60.77 and its 200-day simple moving average is $61.76. The firm has a market cap of $9.55 billion, a PE ratio of 45.21 and a beta of 1.48. Cognex Corporation has a 52 week low of $34.60 and a 52 week high of $72.88.

Cognex (NASDAQ:CGNX - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.42 by $0.03. Cognex had a net margin of 16.05% and a return on equity of 13.50%. The firm had revenue of $291.26 million during the quarter, compared to analyst estimates of $292.10 million. During the same quarter in the prior year, the firm posted $0.25 earnings per share. Cognex's quarterly revenue was up 16.9% on a year-over-year basis. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. Research analysts expect that Cognex Corporation will post 1.68 EPS for the current year.

Cognex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 3rd. Investors of record on Thursday, August 20th were issued a $0.0850 dividend. The ex-dividend date was Thursday, August 20th. This represents a $0.34 dividend on an annualized basis and a yield of 0.6%. Cognex's dividend payout ratio is currently 33.01%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. Truist Financial set a $74.00 target price on Cognex and gave the company a "hold" rating in a report on Monday, October 5th. Wall Street Zen downgraded Cognex from a "buy" rating to a "hold" rating in a research report on Sunday, September 13th. HSBC lowered Cognex from a "buy" rating to a "hold" rating and set a $65.00 price target on the stock. in a research note on Monday, August 10th. The Goldman Sachs Group reiterated a "buy" rating and set a $91.00 price target on shares of Cognex in a research report on Friday, August 7th. Finally, Cantor Fitzgerald increased their price objective on Cognex from $76.00 to $84.00 and gave the company an "overweight" rating in a research note on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $75.57.

Cognex Profile

Cognex Corporation develops machine vision and industrial identification technologies that help manufacturers and businesses automate inspection, measurement, guidance, and tracking processes. Its systems use cameras, sensors, software, and artificial intelligence to analyze images and identify products, defects, components, and other objects.

The company's product portfolio includes vision systems, industrial cameras, vision sensors, barcode readers, optical character recognition tools, three-dimensional vision systems, and machine vision software.

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.